within Pharmacolibrary.Drugs.ATC.M;

model M01AE17_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.23 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,
    adminCount     = 1,
    Vd             = 0.00020999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dexketoprofen is a non-steroidal anti-inflammatory drug (NSAID) and the S(+)-enantiomer of ketoprofen. It is used for the treatment of mild to moderate pain, including musculoskeletal pain, dysmenorrhea, and dental pain. It is currently approved and in use in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported after intravenous administration, healthy adult volunteers.</p><h4>References</h4><ol><li><p>Valles, J, et al., &amp; Capriati, A (2006). Clinical pharmacokinetics of parenteral dexketoprofen trometamol in healthy subjects. <i>Methods and findings in experimental and clinical pharmacology</i> 28 Suppl A 7–12. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16801987/&quot;>https://pubmed.ncbi.nlm.nih.gov/16801987</a></p></li><li><p>Piirainen, P, et al., &amp; Kokki, M (2018). The analgesic efficacy and pharmacokinetics of epidural oxycodone after gynaecological laparotomy: a randomized, double-blind, double-dummy comparison with intravenous administration. <i>British journal of clinical pharmacology</i> 84(9) 2088–2096. DOI:<a href=&quot;https://doi.org/10.1111/bcp.13643&quot;>10.1111/bcp.13643</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29782641/&quot;>https://pubmed.ncbi.nlm.nih.gov/29782641</a></p></li><li><p>Piirainen, A, et al., &amp; Kokki, H (2016). The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty. <i>Clinical drug investigation</i> 36(7) 545–555. DOI:<a href=&quot;https://doi.org/10.1007/s40261-016-0400-4&quot;>10.1007/s40261-016-0400-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27086319/&quot;>https://pubmed.ncbi.nlm.nih.gov/27086319</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AE17_1;
